MAXIPIME Drug Patent Profile
✉ Email this page to a colleague
When do Maxipime patents expire, and when can generic versions of Maxipime launch?
Maxipime is a drug marketed by Hospira Inc and is included in one NDA.
The generic ingredient in MAXIPIME is cefepime hydrochloride. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Maxipime
A generic version of MAXIPIME was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.
Summary for MAXIPIME
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Clinical Trials: | 6 |
Patent Applications: | 5,978 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MAXIPIME |
DailyMed Link: | MAXIPIME at DailyMed |
Recent Clinical Trials for MAXIPIME
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yasser Esmat Mohammed | Phase 2/Phase 3 |
Assiut University | Phase 2/Phase 3 |
Acellena Contract Drug Research and Development | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for MAXIPIME
US Patents and Regulatory Information for MAXIPIME
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira Inc | MAXIPIME | cefepime hydrochloride | INJECTABLE;INJECTION | 050679-002 | Jan 18, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira Inc | MAXIPIME | cefepime hydrochloride | INJECTABLE;INJECTION | 050679-003 | Jan 18, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira Inc | MAXIPIME | cefepime hydrochloride | INJECTABLE;INJECTION | 050679-001 | Jan 18, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |